ProfileGDS5678 / 1425832_a_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 3% 3% 3% 96% 3% 3% 3% 3% 3% 5% 3% 3% 3% 3% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 11.960753
GSM967853U87-EV human glioblastoma xenograft - Control 21.940853
GSM967854U87-EV human glioblastoma xenograft - Control 31.941313
GSM967855U87-EV human glioblastoma xenograft - Control 49.074296
GSM967856U87-EV human glioblastoma xenograft - Control 51.887373
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 11.989563
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 21.940823
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 31.925343
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 41.921423
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.038565
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 21.925663
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 31.967033
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 41.929523
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 51.930833